Skip to content
Established in May 2022, the SET is a non-vesting, perpetual trust funded with 40 million Shoprite Checkers shares valued at R8.9 billion ($478.07 million).
This uptrend adds to his previous gains, with his stake increasing by $8.6 million between Jan. 4 and Mar. 9.
This surge not only cements Le Roux’s status among South Africa’s billionaires but also strengthens his reputation as a key investor on the JSE.
This surge in Mouton’s stake solidifies his spot among the most affluent investors on the JSE.
Motsepe, boasting a net worth of $2.5 billion, derives a significant portion of his wealth from his substantial stake in ARM, cementing his position as one of Africa’s leading industrialists.
Econet Wireless Zimbabwe’s strategic restructuring with EcoCash signifies a pivotal step in consolidating its position within the financial technology sector.
This substantial gain solidifies Jawno’s position as one of the wealthiest investors on the JSE.
This is attributed to lower global nitrogen pricing and a reduction in natural gas prices in Europe and the United States following the exceptional highs of 2022.
Amid the recent market volatility, the market value of Calisto’s stake has dropped significantly by $34.52 million, falling from $609.57 million on March 21 to $575.05 million.
The recent gain not only reinforces Mwangi’s standing as one of the top investors on the NSE but also strengthens his position as Kenya’s wealthiest banker.
The founders, Ramachandran Ottapathu and Farouk Ismail, are poised to benefit from the dividend payout.
This recent boost follows a previous rise in Ellison’s wealth, with his stake in Lowe’s seeing a $3.3-million uptick between Jan. 24 and Feb. 14.
This recent gain strengthens Ovia’s position as Nigeria’s wealthiest banker, underscoring his success as a leading figure in the financial services industry.
The proposed dividend marks a significant milestone for the group and reflects its strong financial position.
Aspen anticipates a robust second half of 2024, supported by the launch of sterile manufacturing contracts and continued growth in its active pharmaceutical ingredients (API) business.
This further cements Bekker’s position as a leading South African business figure and a top investor on the Johannesburg Stock Exchange (JSE).
